ViraFend® is a unique natural supplement whose active ingredient – Activated Humic Acid – has been demonstrated to be a significant Virus Attachment Inhibitor, in that it works to interfere with a virus’ ability to complete its attachment to a human host cell. If a virus, such as the Cold Sore/Herpes viruses, or Flu viruses (Types A and B), or the Shingles virus (H. zoster), or other viruses including many respiratory viruses, cannot attach to a human host cell, they are unable to insert their genetic material into the host cell, and cannot trick the host cell into acting as an incubator to reproduce the virus.
ViraFend® has been demonstrated in numerous scientific studies to effectively ‘coat’ the outside envelope of a virus, interfering with its ability to complete its attachment to its target human host cell.
ViraFend® Virus Defense Formula is a vegetarian capsule taken as a dietary supplement twice a day (one tablet 2x per day), with or without food. There are no known side effects, and ViraFend® can be taken with any other medication, including any antiviral prescriptions such as acyclovir if recommended by your doctor.
Each vegetarian capsule contains:
200mg of activated humic acid (virus attachment inhibitor)
75mg of pharmaceutical grade L-lysine (immune booster to oppose levels of L-arginine in the body that viruses need to survive)
Each bottle contains 60 vegetarian capsules, a one-month supply.
Directions For Use:
Adults 12 and over: take 1 vegetarian capsule twice per day; once in the morning and once in the early evening, with or without food.
Dietary Supplement FDA Required Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Always ask your doctor before starting any new dietary supplement, or if you have any medical conditions. Always follow the advice of your doctor or qualified healthcare provider.
ViraFend® is a registered trademark of, and available here under license from Viralogics Corporation.